20 November 2018 - Sen. Bernie Sanders and Rep. Ro Khanna on Tuesday unveiled a bill aimed at aggressively lowering drug prices by stripping monopolies from drug companies if their prices are deemed excessive.

Sanders has long railed against drug companies for their prices, and this bill is one of the most far-reaching proposals aimed at lowering them.

The bill would strip the monopoly from a company, regardless of any patents, and allow other companies to create cheaper generic versions of a drug if the price for that drug is higher than the median price in Canada, the United Kingdom, Germany, France and Japan.

Read The Hill article